K181186

Substantially Equivalent

Solitare Platinum Revascularization Device

Applicant: Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
Product code: POL
Advisory panel: Neurology
Date received: 2018-05-03
Decision date: 2018-10-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irvine, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.